Entropy Neurodynamics Limited

A$0.03As of Sun 8 Nov 2026, 12:00 UTC
ASX:ENPHealthcare
Country Australia
PE (Fwd) •••
TSR 2Y CAGR 9.97%
Div yield —
ROE (73.07%)
Biotechnology
Beta (5Y) (0.14)
PE TTM —
TSR TTM (23.68%)
Mkt cap A$47.37M
ROIC (45.59%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.0369
27.19%
101.02%
Hold 2|3|1|5|6
2Q26
3Q26
4Q26
1Q27
Earnings per share$
—
—
—
—
17.76%
17.41%
11.82%
4.10%
Revenue$M
2.167
2.225
2.203
2.175
1.78%
6.81%
5.94%
1.94%
Peers (US$32.54M)
Cap (US$)
PE
32.55M
24.18x
Capital
TTM
5Y
10Y
Leveragex
0.803
1.132
0.980
EBIT/Intx
1.906
0.388
0.396
Own earn%
(121.00)
86.75
87.69
Sh yield%
11.89
49.09
48.33
Owners
Insiders/Inst%
14.27
61.09
Short interest%
5.66
SBC / revenue%
1.81
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
0–5
$1 testx
0.6
Incr. ROIC%
4